Latest News
AKL Research and Development names new advisors
12 December 2018 - AKL Research and Development, a company developing an investigational osteoarthritis (OA) medicine, announced yesterday that it has named Dr Annalisa Jenkins and Lord Michael Grade as its advisors.Dr Jenkins is former head of Globa...
BiomX names new chief medical officer
12 December 2018 - BiomX Ltd, a microbiome company developing customised phage therapies, announced yesterday that it has named Dr Sailaja Puttagunta, MD, as its new chief medical officer.Dr Puttagunta will manage the company's clinical developm...
US Food and Drug Administration approves New Drug Application for Mayne Pharma Group's Tolsura 65mg capsules
12 December 2018 - The United States Food and Drug Administration (FDA) has approved the New Drug Application for Australia-based Mayne Pharma Group Limited's (ASX: MYX) Tolsura (SUBA-itraconazole) 65mg capsules, it was reported yesterday.The pr...
e-therapeutics signs research collaboration with Novo Nordisk
12 December 2018 - United Kingdom-based e-therapeutics has signed a research collaboration with Novo Nordisk, a Danish drug manufacturer, intended to discover biological mechanisms and therapies to treat type-2 diabetes, it was reported yesterday.Acc...
Hansa Medical's EGM resolves on name change
12 December 2018 - Biopharmaceutical company Hansa Medical AB (STO:HMED) announced on Tuesday that at the extraordinary general meeting, held on 11 December 2018, it was resolved to change Hansa Medical's company name to Hansa Biopharma AB, in a...